NEURIDAN
Live / Applied — Second extension granted (statement of use) (as of 19 Dec 2025)
What this means for you
Not registered yet, but its 17 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98505482
- Mark type
- Stylized text
- Filed
- 17 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Jon Deppe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting metabolism; pharmaceutical preparations and substances for treatment of neurological and metabolic-related diseases and disorders; ketone ester beverages for use as dietary supplements and medical foods; dietetic foods adapted for medical purposes; homogenized food adapted for medical purposes; dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes
Owner
- NeuroEnergy Ventures, Inc., Cary, NC, US
- NeuroEnergy Ventures, Inc., New York, NY, US
Prosecution history
- 20 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2025 — SOU EXTENSION 2 GRANTED
- 19 Dec 2025 — SOU EXTENSION 2 FILED
- 19 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2025 — SOU EXTENSION 1 GRANTED
- 20 Jun 2025 — SOU EXTENSION 1 FILED
- 20 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 22 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED